Literature DB >> 11078919

Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: a 10-year prospective cohort study in Japan.

M Inoue1, K Tajima, A Matsuura, T Suzuki, T Nakamura, K Ohashi, S Nakamura, S Tominaga.   

Abstract

Chronic atrophic gastritis is regarded as a predisposing factor for gastric cancer associated with Helicobacter pylori infection, and its severity is suggested to be a key influence on gastric cancer risk. Our purpose was to elucidate chronological change in cumulative risk of gastric cancer occurrence with various degrees of chronic atrophic gastritis by long-term follow-up. A total of 5373 subjects without cancer or resected stomachs who underwent gastroscopic examination and completed a life-style questionnaire between 1985-1989 were prospectively followed until December 1999. Relative risks of gastric cancer associated with baseline endoscopic findings were estimated using hazard ratios and their 95% confidence intervals with the Cox proportional hazard model, adjusting for gender, age and gastric cancer family history. After an average of 10 years of follow-up, 117 gastric cancer cases were identified. The risk was greatest among the subjects with moderate atrophy at baseline (hazard ratio: 2.22) and 4-6 years of follow-up (hazard ratio: 4.6-5.0). After this time point, risk attenuation with the length of follow-up period was observed. Our study gives the supportive evidence to the hypothesis that incomplete chronic atrophic gastritis and the processes occurring in atrophy are associated with development of gastric cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11078919     DOI: 10.1016/s0304-3835(00)00603-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer.

Authors:  Kentaro Sugano
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

2.  Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.

Authors:  Zhong-Wu Li; Ying Wu; Yu Sun; Lu-Ying Liu; Meng-Meng Tian; Guo-Shuang Feng; Wei-Cheng You; Ji-You Li
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

3.  Detection and location of Helicobacter pylori in human gastric carcinomas.

Authors:  Yun-Lian Tang; Run-Liang Gan; Bi-Hua Dong; Ri-Chen Jiang; Rong-Jun Tang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

4.  Helicobacter pylori infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China.

Authors:  Run-Tian Wang; Tao Wang; Kun Chen; Ji-Yao Wang; Jie-Ping Zhang; San-Ren Lin; Yi-Min Zhu; Wen-Ming Zhang; Yu-Xin Cao; Chou-Wen Zhu; Hai Yu; Yu-Jun Cong; Shu Zheng; Bing-Quan Wu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori.

Authors:  Akira Tari; Yasuhiko Kitadai; Masaharu Sumii; Atsunori Sasaki; Hiroshi Tani; Sinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

Review 6.  Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.

Authors:  Andrew D Spence; Chris R Cardwell; Úna C McMenamin; Blanaid M Hicks; Brian T Johnston; Liam J Murray; Helen G Coleman
Journal:  BMC Gastroenterol       Date:  2017-12-11       Impact factor: 3.067

7.  Differential expression of phospholipase C epsilon 1 is associated with chronic atrophic gastritis and gastric cancer.

Authors:  Jun Chen; Wei Wang; Tao Zhang; Jiajia Ji; Qirong Qian; Lungeng Lu; Hualin Fu; Weilin Jin; Daxiang Cui
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

8.  The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile.

Authors:  Oi Lian Kon; Tai-Tung Yip; Meng Fatt Ho; Weng Hoong Chan; Wai Keong Wong; Soo Yong Tan; Wai Har Ng; Siok Yuen Kam; Alvin Kh Eng; Patrick Ho; Rosa Viner; Hock Soo Ong; M Priyanthi Kumarasinghe
Journal:  BMC Med Genomics       Date:  2008-10-25       Impact factor: 3.063

9.  Evaluation and clinical significance of the stomach age model for evaluating aging of the stomach-a multicenter study in China.

Authors:  Qin-Yan Gao; Zhen-Hua Wang; Yun Cui; Jian-Qiu Sheng; Kun-He Zhang; Rui-Hua Shi; Jian-Ming Xu; Wei-Chang Chen; Xiu-Li Zuo; Shu-De Li; Yue-Xiang Chen; Yan-Yan Song; Jing-Yuan Fang
Journal:  BMC Clin Pathol       Date:  2014-06-28

10.  Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.

Authors:  Fumie Ikeda; Kentaro Shikata; Jun Hata; Masayo Fukuhara; Yoichiro Hirakawa; Tomoyuki Ohara; Naoko Mukai; Masaharu Nagata; Daigo Yoshida; Koji Yonemoto; Motohiro Esaki; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  J Epidemiol       Date:  2016-06-04       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.